Motley Fool  4 hrs ago  Comment 
Shares shot up 33% on Thursday, fueled by rumors that the company is about to accept a takeover bid.
FiercePharma  11 hrs ago  Comment 
Sanofi on verge of $1B-plus deal for arthritis-focused biotech Flexion: source aliu Thu, 03/23/2017 - 09:34
The Times of India  Mar 23  Comment 
PHARMACEUTICALS-EUROPE/FDA:Crunch week looms for Sanofi, Roche and GSK at U.S. drugs agency
FiercePharma  Mar 22  Comment 
Sanofi exec fires back amid fight over Zika vaccine license esagonowsky Wed, 03/22/2017 - 15:46
FiercePharma  Mar 21  Comment 
Sanofi, Regeneron ask court to shield Dupixent from Amgen patent attack tracy Tue, 03/21/2017 - 14:55
newratings.com  Mar 21  Comment 
PARIS (dpa-AFX) - Sanofi (SNYNF, SNY) said that its social experiment in 160 participants have shown that allergy sufferer's sleep could be disrupted nearly 4 times more than a normal person. The makers of Xyzal Allergy 24 HR said half of the...
Wall Street Journal  Mar 21  Comment 
French pharmaceutical company Sanofi expects its drug sales in China—its third-largest market after the U.S. and France—to grow at least 10% this year, matching last year’s pace.
SeekingAlpha  Mar 20  Comment 
FiercePharma  Mar 18  Comment 
Sanofi debuts first Xyzal ad campaign with wise old spokes-owl beth.bulik Sat, 03/18/2017 - 14:09
GenEng News  Mar 15  Comment 
Patients with severe atopic dermatitis in the U.K. will have access to Sanofi and Regeneron's investigational drug dupilumab through the Early Access to Medicines Scheme (EAMS) before full marketing authorization has been granted. The go-ahead to...

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki